Sign in:
Email
 Password  save:
  
 Company Reports 
 
   
My Recent Searches
  Help
 
   
 
 
Get Insiders for : 
ICU Medical Inc (ICUI)  
$96.72 1.04 (1.06%) as of 4:30 Wed 4/24


Download
   
Exchange: Nasdaq National Market
Security Type: Common
Shares Out: 23,910,000
Market Cap: 2.31(B)
Last Volume: 171,083 Avg Vol: 186,510
52 Week Range: $81.08 - $209.15
Level I Sector: Health Care
Level II Sector: Health Services
Level III Sector: Medical Instruments & Supplies

Member Indexes:

    S&P COMPOSITE 1500     NASDAQ COMPOSITE
    S&P SMALLCAP 600     NASDAQ NNM COMPOSITE

Rankings:

     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  789
Guru Rank Value     : 1
Guru Occurances    : 1

 

            6 Months   1 Year   2 Year  
 
Company Profile   ICU Medical is an infusion therapy company. Co. has four product lines: Infusion Consumables, which include Clave™ needlefree products, SwabCap and SwabTip disinfecting caps, ClearGuard HD antimicrobial barrier caps for hemodialysis catheters and Tego™ hemodialysis connector used to cap and protect hemodialysis central venous catheter hubs; Infusion Systems, which provide infusion pumps, dedicated IV sets, software and other services; IV Solutions, which provide a supply of IV solutions, irrigation and nutritionals; and Critical Care, which helps clinicians get real-time access to patients' hemodynamic and cardiac status with a portfolio of monitoring systems and sensors and catheters.


 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 0 0 25,835
Total Buy Value $0 $0 $0 $4,467,256
Total People Bought 0 0 0 1
Total Buy Transactions 0 0 0 1
Total Shares Sold 1,731,983 1,733,712 1,800,756 1,804,487
Total Sell Value $183,670,269 $183,822,465 $195,804,141 $196,491,165
Total People Sold 6 6 8 8
Total Sell Transactions 12 13 17 23
End Date 2024-01-25 2023-10-24 2023-04-25 2022-04-25

   
Records found: 1476
  Page 1 of 60  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

 
3m +/-  
Form
   Jain Vivek Chairman and CEO   •       •      –    2024-03-15 4 D $98.08 $261,972 D/D (2,671) 104,593     -
   Jain Vivek Chairman and CEO   •       •      –    2024-03-15 4 OE $0.00 $0 D/D 4,871 107,264     -
   Woolson Daniel VP, GM-Infusion Capital   •       –      –    2024-03-15 4 D $98.08 $126,916 D/D (1,294) 15,609     -
   Woolson Daniel VP, GM-Infusion Capital   •       –      –    2024-03-15 4 OE $0.00 $0 D/D 2,923 16,903     -
   Sanzone Virginia Ruth VP, General Counsel   •       –      –    2024-03-15 4 D $98.08 $87,291 D/D (890) 6,532     -
   Sanzone Virginia Ruth VP, General Counsel   •       –      –    2024-03-15 4 OE $0.00 $0 D/D 1,624 7,422     -
   Bonnell Brian Michael Chief Financial Officer   •       –      –    2024-03-15 4 D $98.08 $174,582 D/D (1,780) 24,954     -
   Bonnell Brian Michael Chief Financial Officer   •       –      –    2024-03-15 4 OE $0.00 $0 D/D 3,247 26,734     -
   Voigtlander Christian B. Chief Operating Officer   •       –      –    2024-03-15 4 D $98.08 $174,582 D/D (1,780) 12,539     -
   Voigtlander Christian B. Chief Operating Officer   •       –      –    2024-03-15 4 OE $0.00 $0 D/D 3,247 14,319     -
   Sousa Ben Chief Information Officer   •       –      –    2024-03-15 4 D $98.08 $45,411 D/D (463) 3,319     -
   Sousa Ben Chief Information Officer   •       –      –    2024-03-15 4 OE $0.00 $0 D/D 1,299 3,782     -
   Woolson Daniel VP, GM-Infusion Capital   •       –      –    2024-03-15 4 S $98.27 $77,733 D/D (791) 13,980 0%     
   Lopez George A Director   –       •      –    2024-03-14 4 S $101.87 $812,741 I/I (7,978) 877,343 1%     
   Lopez George A Director   –       •      –    2024-03-12 4/A S $101.51 $154,497 I/I (1,522) 885,321     -
   Lopez George A Director   –       •      –    2024-03-12 4 S $101.51 $154,497 D/D (1,522) 316,231 3%     
   Lopez George A Director   –       •      –    2024-03-11 4 S $104.22 $196,968 D/D (1,890) 317,753 6%     
   Lopez George A Director   –       •      –    2024-03-08 4 S $105.94 $1,628,454 D/D (15,372) 319,643 6%     
   Jain Vivek Chairman and CEO   •       •      –    2024-03-08 4 D $104.52 $622,208 D/D (5,953) 102,393     -
   Jain Vivek Chairman and CEO   •       •      –    2024-03-08 4 OE $0.00 $0 D/D 10,856 106,962     -
   Woolson Daniel VP, GM-Infusion Capital   •       –      –    2024-03-08 4 D $104.52 $93,441 D/D (894) 14,771     -
   Woolson Daniel VP, GM-Infusion Capital   •       –      –    2024-03-08 4 OE $0.00 $0 D/D 2,020 15,665     -
   Sanzone Virginia Ruth VP, General Counsel   •       –      –    2024-03-08 4 D $104.52 $130,232 D/D (1,246) 5,798     -
   Sanzone Virginia Ruth VP, General Counsel   •       –      –    2024-03-08 4 OE $0.00 $0 D/D 2,273 7,044     -
   Sanzone Virginia Ruth VP, General Counsel   •       –      –    2024-03-08 4 S $104.57 $345,088 D/D (3,300) 4,771 6%     

  1476 Records found
  1  2  3  4  5  6  7  8  9  Next   
  Page 1 of 60
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed